CHIROGATE INTERNATIONAL INC

Overview

CHIROGATE INTERNATIONAL INC is an active pharmaceutical ingredient (API) supplier with 14 active FDA Type II Drug Master Files, covering BIMATOPROST; CARBOPROST TROMETHAMINE; DINOPROSTONE; HEXADECYL TREPROSTINIL; ILOPROST; ISOMER FREE LATANOPROST.

API / Drug Master Files

CHIROGATE INTERNATIONAL INC holds 14 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ILOPROSTActive2025-02-04
• DINOPROSTONEActive2023-04-26
• LATANOPROSTENE BUNODActive2023-04-24
• CARBOPROST TROMETHAMINEActive2019-07-09
• TAFLUPROSTActive2019-04-11
• TRAVOPROST (ISOMER FREE)Active2018-07-27
• ISOMER FREE LATANOPROSTActive2017-03-14
• TREPROSTINIL SODIUMActive2016-08-15
• HEXADECYL TREPROSTINILActive2015-08-12
• TREPROSTINILActive2014-09-16
• UNOPROSTONE ISOPROPYLActive2014-06-17
• TRAVOPROSTActive2009-04-20
• BIMATOPROSTActive2008-02-26
• LATANOPROSTActive2005-05-24

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHIROGATE INTERNATIONAL INC in our records. PharmaTek screens the full directory against live FDA enforcement data.